Gene · 3908
NIH grants1,398
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 1,398
Download this page as JSON| Grant | Title | LAMA2 papers | Newest fiscal year |
|---|---|---|---|
| R01HL169632 | Coordinated Heart Stimulation Testbed: A Platform for Contractile Ventricle Engineering | 1 | 2025 |
| R01LM012806 | Predicting Phenotype by Deep Learning Heterogeneous Multi-Omics Data | 1 | 2025 |
| R01MH108579 | The role of the clustered protocadherins in neural circuit formation and implications for neurodevelopmental disorders | 1 | 2025 |
| R01MH110438 | Novel Developmental Pathways Underlying Psychiatric Disorders | 1 | 2025 |
| R01MH113257 | Yale Macaque Brain Resource | 1 | 2025 |
| R01NS032457 | Cell Identity Determination in Human Brain: Somatic Mutation and Cell Lineage | 1 | 2025 |
| R01NS082347 | Imaging Neurodegeneration in Multiple Sclerosis | 1 | 2025 |
| R01NS085238 | Genetic modifiers of Duchenne Muscular Dystrophy | 1 | 2025 |
| R01NS098273 | Development and function of the meninges arachnoid barrier | 1 | 2025 |
| R01NS121078 | Human 3D Neuro-Vascular Interaction and Meningeal Lymphatic Models with Application to Alzheimer’s Disease | 1 | 2025 |
| R01NS136281 | Laminin protein therapy for the treatment of Laminin-alpha2 deficient congenital muscular dystrophy | 1 | 2025 |
| R24AA025017 | Clinical Resource for Alcoholic Hepatitis Inestigation | 1 | 2025 |
| R35CA220500 | Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes | 1 | 2025 |
| R35GM118173 | Chemical Synthesis of Complex Natural Products for Translational Science | 1 | 2025 |
| R35GM138113 | Illuminating Post-Transcriptional Regulation through Proteogenomic Integration | 1 | 2025 |
| R35GM146769 | Regulation of Ribosome Biogenesis | 1 | 2025 |
| R37DA023999 | Origin of Cortical Species-specific Distinctions | 1 | 2025 |
| R38HL143615 | Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program | 1 | 2025 |
| R50CA211199 | Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level | 1 | 2025 |
| T15LM007079 | Training in Biomedical Informatics at Columbia University | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3908/grants?page=9